EVALUATION OF PROPHAGES AND ANTI MICROBIAL RESISTANCE PROFILE OF BACILLUS SUBTILIS USING IN SILICO APPROACH
Abstract
The main objective of this study was to identify the prophages and antimicrobial resistance profile of Bacillus subtilis using computational methods. Prophages are potential therapeutic antimicrobial agents against antibiotic- resistant pathogens. The potential of prophage to induce antimicrobial resistance and increase pathogenicity in bacterial genomes resulted in renewed interest in the identification of prophage sequences and their associated antimicrobial resistant genes in bacterial genomes. Sequences of Bacillus subtilis retrieved from the sequence raw archive (SRA) of the National Centre for Biotechnology Information was submitted to bacterial viral bioinformatics resource centre for genome assembly. Prophage sequences were identified using the PHASTER server. The region length, region position and GC percentage of nucleotides of prophage sequences were identified. The antimicrobial resistance gene family, drug class, resistance mechanism and length of reference sequences were identified using the resistance gene identifier protocol of the comprehensive antimicrobial resistance database. It can be concluded that the Bacillus subtilis strain evaluated contained prophage sequences associated with antimicrobial resistance genes, there is, therefore, the need to assess the safety of bacteriophages before they are utilized as alternative to antibiotics.
References
Alcock R..P., Huynh W., Chalil, R. & Andrew, G.M. (2023). CARD 2023 : Expanded curation, support for machine learning and resistome prediction at the comprehensive antibiotic resistance database. Nucleic Acids Research, 51(1), 690- 699. DOI: https://doi.org/10.1093/nar/gkac920
Alexander, S., Zemphira, A. & Glenn, M (2001). Bacteriophage therapy. Antimicrobial agents and Chemotherapy, 45 (3), 649-659. DOI: https://doi.org/10.1128/AAC.45.3.649-659.2001
Amdt, D., Grant, J., Marcu, A., Sajed, T., Pon, A., Liang, Y. & Wishart, D.S. (2016). PHASTER : A better, faster version of the PHAST phage search tool. Nucleic Acids Research, 44 (1) ,16-21. DOI: https://doi.org/10.1093/nar/gkw387
Domingo, C.P. & Delgado, J. (2018). Bacteriophages protagonists of a post antibiotic era. Antibiotics, 7 , 55-66. DOI: https://doi.org/10.3390/antibiotics7030066
Furtoro, L.L., Pyne, S.P. & Cheng, B.J. (2018). Bacteriophage therapy : Clinical trials and regulatory hurdles. Frontiers in cellular and infection microbiology, 8 : 376 DOI: https://doi.org/10.3389/fcimb.2018.00376
Gorski, A., Wazna, E., Dabrowsi,B., Dabrowskki, K. & Miedzybrodzki, R (2006). Bacteriophage translocation. Immunological and Medicinal Microbiology, 46, 313-319. DOI: https://doi.org/10.1111/j.1574-695X.2006.00044.x
Kakasis, A and Panitsa, G (2019). Bacteriophage therapy as an alternative treatment for human infections. International Journal of Antimicrobial Agents, 53(1), 16-21. DOI: https://doi.org/10.1016/j.ijantimicag.2018.09.004
Minasyan, H.(2017). Sepsis and septic shock pathogenesis and treatment perspectives. Journal of Critical Care , 40, 229-42. DOI: https://doi.org/10.1016/j.jcrc.2017.04.015
Olson, R.D., Assaf, R., Brettin, T & Stevens, R.L. (2023). Introducing the bacterial and viral bioinformatic resource centre. Nucleic Acids Research, 51 (1) , 678-689. DOI: https://doi.org/10.1093/nar/gkac1003
O" Neill, J.(2016). Tackling drug resistant infections globally: Final report and recommendations. The Review of Antimicrobial resistance.
Pouilot, F., Chomtom, M., Bloi, H., Courroux, C. & Bidet, P. (2012). Efficacy of bacteriophage Therapy in experimental sepsis and meningitis caused by a clone Escherichia coli strain. Antimicrobial agents and Chemotherapy, 56 , 3568-3575. DOI: https://doi.org/10.1128/AAC.06330-11
Copyright (c) 2024 FUDMA JOURNAL OF SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
FUDMA Journal of Sciences
